TAKEDA PHARMACEUTIC-SP ADR (TAK) Institutional Ownership Changes & 13F Activity
TAKEDA PHARMACEUTIC-SP ADR (TAK). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Adage Capital Partners Gp, L.L.C., Fmr Llc, D. E. Shaw & Co., Inc., Capital Wealth Planning, Llc, and Goldman Sachs Group Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| M&T Bank Corp | Buy | +36,140 | +125.4% | 64,950 | $1.20M | Q1 2026 | Sep 04, 2026 |
| Cornerstone Financial Management Llc | Buy | +84 | +70.0% | 204 | $3.78K | Q1 2026 | Aug 28, 2026 |
| Brighton Jones Llc | Buy | +10,977 | — | 10,977 | $203.29K | Q1 2026 | Aug 07, 2026 |
| Wells Fargo & Company/Mn | Buy | +75,561 | +7.1% | 1,136,022 | $21.04M | Q1 2026 | Jul 08, 2026 |
| Western Wealth Management, Llc | Buy | +447 | — | 447 | $8.28K | Q1 2026 | May 19, 2026 |
| Silicon Valley Capital Partners | Buy | +39 | — | 39 | $722.00 | Q1 2026 | May 19, 2026 |
| Bank Of America Corp | Sell | -42,899 | -11.8% | 319,969 | $5.93M | Q1 2026 | May 18, 2026 |
| Sunbelt Securities, Inc. | Sell | -7 | -16.7% | 35 | $648.00 | Q1 2026 | May 18, 2026 |
| Adage Capital Partners Gp, L.L.C. | Buy | +6,424,984 | — | 6,424,984 | $118.99M | Q1 2026 | May 15, 2026 |
| Fmr Llc | Buy | +3,060,618 | +75.4% | 7,117,486 | $131.82M | Q1 2026 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Sell | -1,691,207 | -39.4% | 2,602,543 | $48.20M | Q1 2026 | May 15, 2026 |
| Capital Wealth Planning, Llc | Buy | +886,835 | — | 886,835 | $16.42M | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Buy | +814,147 | +16.9% | 5,618,728 | $104.06M | Q1 2026 | May 15, 2026 |
| Brandes Investment Partners, Lp | Buy | +548,760 | +14.1% | 4,430,642 | $82.06M | Q1 2026 | May 15, 2026 |
| Two Sigma Investments, Lp | Buy | +311,700 | — | 311,700 | $5.77M | Q1 2026 | May 15, 2026 |
| Us Bancorp \De\ | Buy | +292,697 | +134.6% | 510,225 | $9.45M | Q1 2026 | May 15, 2026 |
| Citadel Advisors Llc | Buy | +234,426 | +60.2% | 624,160 | $11.56M | Q1 2026 | May 15, 2026 |
| Trexquant Investment Lp | Buy | +229,460 | — | 229,460 | $4.25M | Q1 2026 | May 15, 2026 |
| Quantinno Capital Management Lp | Buy | +219,999 | +20.6% | 1,289,326 | $23.88M | Q1 2026 | May 15, 2026 |
| Aqr Capital Management Llc | Buy | +215,146 | +31.7% | 894,423 | $16.56M | Q1 2026 | May 15, 2026 |
| Vestmark Advisory Solutions, Inc. | Buy | +156,248 | +82.4% | 345,822 | $6.40M | Q1 2026 | May 15, 2026 |
| Price T Rowe Associates Inc | Buy | +140,193 | — | 140,193 | $2.60M | Q1 2026 | May 15, 2026 |
| Charles Schwab Investment Management Inc | Buy | +126,656 | +30.6% | 540,348 | $10.01M | Q1 2026 | May 15, 2026 |
| American Century Companies Inc | Buy | +106,759 | +26.1% | 515,359 | $9.54M | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Buy | +96,398 | +1.5% | 6,469,600 | $119.82M | Q1 2026 | May 15, 2026 |
| Focus Partners Wealth | Sell | -79,662 | -14.2% | 482,387 | $8.87M | Q1 2026 | May 15, 2026 |
| Royal Bank Of Canada | Buy | +60,725 | +11.0% | 614,851 | $11.39M | Q1 2026 | May 15, 2026 |
| Squarepoint Ops Llc | Buy | +54,391 | — | 54,391 | $1.01M | Q1 2026 | May 15, 2026 |
| Advisory Services Network, Llc | Buy | +52,964 | — | 52,964 | $980.89K | Q1 2026 | May 15, 2026 |
| Van Eck Associates Corp | Sell | -45,293 | -2.0% | 2,260,104 | $41.86M | Q1 2026 | May 15, 2026 |
Frequently asked questions about TAK activity
Which institutional owners are buying TAK?
Institutional owners buying TAK include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TAK activity?
"Buy" means an investor increased their reported position in TAK compared to the prior reporting period. This reflects growing exposure to TAKEDA PHARMACEUTIC-SP ADR (TAK) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TAK increasing?
Institutional interest in TAK can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related TAK Institutional Insights
- TAK Overview
- TAK 13F Institutional Holders
- TAK Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TAK Insider Trading & SEC Form 4 Activity
- TAK Articles
- Top Institutional Investor Stock Rankings